,

Hydroxychloroquine and COVID-19

Hydroxychloroquine and COVID-19 - هیدروکسی کلروکین و درمان کرونا

The anti-inflammatory drug hydroxychloroquine does not significantly reduce admission to intensive care or death in patients hospitalized with pneumonia due to covid-19, finds a study from France published by The BMJ today. Adverse events were more common in those receiving the drug.

Release date: 15 May 2020

Source: BMJ

You might also like
One third of patients hospitalised with severe COVID19 still have lung changes after a year - احتمال ماندگاری عوارض ریوی کرونا One third of patients hospitalised with severe COVID-19 still have lung changes after a year
Evaporation Critical to Coronavirus Transmission as Weather Changes - تاثیر آب و هوا در انتشار کرونا Evaporation Critical to Coronavirus Transmission as Weather Changes
Researchers Create Air Filter Designed to Trap and Kill the Coronavirus - محققان نوعی فیلتر هوا ساخته اند که می تواند کرونا ویروس را از بین ببرد Researchers Create Air Filter Designed to Trap and Kill the Coronavirus
High rate of asymptomatic cases in COVID-19 - کرونا و ناقلین بی علامت High rate of asymptomatic cases in COVID-19
Covering faces around kids wont mask emotions - کودکان از پشت ماسک هم می توانند احساسات دیگران را تشخیص دهند Covering faces around kids won’t mask emotions
School Closures May Not Reduce Coronavirus Deaths as Much as Expected - تعطیلی مدارس به وقت کرونا School Closures May Not Reduce Coronavirus Deaths as Much as Expected